#ASCO26: Key head and neck cancer readouts from J&J, Corbus, Summit, Akero and Bicara

Head and neck cancer has always been a tough nut to crack. These tumors can suppress immune responses through multiple pathways, meaning blocking one of those usually isn’t enough. Merck’s Keytruda is approved for head ...